{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:52:54Z","timestamp":1790351574883,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["381280"],"award-info":[{"award-number":["381280"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reumafonds"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s40744-021-00331-x","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T13:02:37Z","timestamp":1626613357000},"page":"1303-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study"],"prefix":"10.1007","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-5612","authenticated-orcid":false,"given":"Luiza R.","family":"Grazziotin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinka","family":"Twilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Ijzerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M. A.","family":"Kip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Koffijberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost F.","family":"Swart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiaan J.","family":"Vastert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico M.","family":"Wulffraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae S. M.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia J.","family":"Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paivi M.","family":"Miettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrike","family":"Schmeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the UCAN CAN-DU, UCAN CURE consortia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,18]]},"reference":[{"issue":"9783","key":"331_CR1","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138\u201349.","journal-title":"Lancet"},{"issue":"9563","key":"331_CR2","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767\u201378.","journal-title":"Lancet"},{"issue":"2","key":"331_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00296-014-3085-0","volume":"35","author":"NJ Shiff","year":"2015","unstructured":"Shiff NJ, Lix LM, Oen K, et al. Chronic inflammatory arthritis prevalence estimates for children and adolescents in three Canadian provinces. Rheumatol Int. 2015;35(2):345\u201350.","journal-title":"Rheumatol Int"},{"issue":"5","key":"331_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00002281-200109000-00009","volume":"13","author":"DT Kulas","year":"2001","unstructured":"Kulas DT, Schanberg L. Juvenile idiopathic arthritis. Curr Opin Rheumatol. 2001;13(5):392\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"331_CR5","first-page":"ep29","volume":"91","author":"LJ McCann","year":"2006","unstructured":"McCann LJ, Wedderburn LR, Hasson N. Juvenile idiopathic arthritis. Arch Dis Child. 2006;91(2):ep29\u2013ep36.","journal-title":"Arch Dis Child"},{"issue":"2","key":"331_CR6","first-page":"142","volume":"23","author":"MS Mullick","year":"2005","unstructured":"Mullick MS, Nahar JS, Haq SA. Psychiatric morbidity, stressors, impact, and burden in juvenile idiopathic arthritis. J Health Popul Nutr. 2005;23(2):142\u20139.","journal-title":"J Health Popul Nutr"},{"issue":"5","key":"331_CR7","first-page":"958","volume":"30","author":"E Thomas","year":"2003","unstructured":"Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol. 2003;30(5):958\u201365.","journal-title":"J Rheumatol"},{"issue":"9","key":"331_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s40273-020-00921-7","volume":"38","author":"LR Grazziotin","year":"2020","unstructured":"Grazziotin LR, Currie G, Kip MMA, et al. Health state utility values in juvenile idiopathic arthritis: what is the evidence? Pharmacoeconomics. 2020;38(9):913\u201326.","journal-title":"Pharmacoeconomics"},{"key":"331_CR9","doi-asserted-by":"publisher","unstructured":"Kip MMA, de Roock S, Currie G, et al. Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system. Expert Rev Pharmacoecon Outcomes Res. 2020;1\u201310. https:\/\/doi.org\/10.1080\/14737167.2021.1857241.","DOI":"10.1080\/14737167.2021.1857241"},{"issue":"6","key":"331_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/rheumatology\/keq432","volume":"50","author":"FH Prince","year":"2011","unstructured":"Prince FH, de Bekker-Grob EW, Twilt M, et al. An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register. Rheumatology. 2011;50(6):1131\u20136.","journal-title":"Rheumatology"},{"issue":"7","key":"331_CR11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00296-011-1894-y","volume":"32","author":"IK Yucel","year":"2012","unstructured":"Yucel IK, Seyahi E, Kasapcopur O, Arisoy N. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever. Rheumatol Int. 2012;32(7):1955\u201362.","journal-title":"Rheumatol Int"},{"issue":"5","key":"331_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11926-015-0508-1","volume":"17","author":"W Gidman","year":"2015","unstructured":"Gidman W, Meacock R, Symmons D. The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication. Curr Rheumatol Rep. 2015;17(5):31.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"331_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12969-019-0321-x","volume":"17","author":"MMA Kip","year":"2019","unstructured":"Kip MMA, Currie G, Marshall DA, et al. Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review. Pediatr Rheumatol Online J. 2019;17(1):20.","journal-title":"Pediatr Rheumatol Online J"},{"key":"331_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10198-016-0786-1","volume":"17","author":"A Kuhlmann","year":"2016","unstructured":"Kuhlmann A, Schmidt T, Treskova M, et al. Social\/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe. Eur J Health Econ. 2016;17:79\u201387.","journal-title":"Eur J Health Econ"},{"issue":"12","key":"331_CR15","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/acr.22903","volume":"68","author":"NJ Luca","year":"2016","unstructured":"Luca NJ, Burnett HF, Ungar WJ, et al. Cost-effectiveness analysis of first-line treatment with biologic agents in polyarticular juvenile idiopathic arthritis. Arthritis Care Res. 2016;68(12):1803\u201311.","journal-title":"Arthritis Care Res"},{"issue":"34","key":"331_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20340","volume":"20","author":"J Shepherd","year":"2016","unstructured":"Shepherd J, Cooper K, Harris P, Picot J, Rose M. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation. Health Technol Assess. 2016;20(34):1\u2013222.","journal-title":"Health Technol Assess"},{"issue":"5","key":"331_CR17","first-page":"920","volume":"36","author":"S Shenoi","year":"2018","unstructured":"Shenoi S, Horneff G, Cidon M, et al. The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review. Clin Exp Rheumatol. 2018;36(5):920\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"331_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.22463","volume":"57","author":"S Bernatsky","year":"2007","unstructured":"Bernatsky S, Duffy C, Malleson P, Feldman DE, St Pierre Y, Clarke AE. Economic impact of juvenile idiopathic arthritis. Arthritis Rheum. 2007;57(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"331_CR19","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00296-017-3734-1","volume":"37","author":"NJ Shiff","year":"2017","unstructured":"Shiff NJ, Oen K, Rabbani R, Lix LM. Validation of administrative case ascertainment algorithms for chronic childhood arthritis in Manitoba. Canada Rheumatol Int. 2017;37(9):1575\u201384.","journal-title":"Canada Rheumatol Int"},{"issue":"2","key":"331_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"key":"331_CR21","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"key":"331_CR22","unstructured":"Alberta Health, Health Analytics Branch, Overview of Administrative Health Datasets. 2017. https:\/\/open.alberta.ca\/dataset\/657ed26d-eb2c-4432-b9cb-0ca2158f165d\/resource\/38f47433-b33d-4d1e-b959-df312e9d9855\/download\/research-health-datasets.pdf. Accessed 5 Dec 2020."},{"key":"331_CR23","unstructured":"Statistics Canada. Table 18-10-0004-08, Consumer Price Index, monthly, percentage change, not seasonally adjusted, Canada, provinces, Whitehorse and Yellowknife \u2014 Health and personal care. https:\/\/doi.org\/10.25318\/1810000401-eng. Accessed 22 Dec 2020."},{"key":"331_CR24","unstructured":"Alberta Health, Health Analytics Branch. Interactive Health Data Application - Hospital Ambulatory Care Case Costing 2015. http:\/\/www.ahw.gov.ab.ca\/IHDA_Retrieval\/ShowMetaDataNotesServlet?1504. Accessed 8 Oct 2020."},{"key":"331_CR25","unstructured":"Alberta Health Care Insurance Plan - Medical Price List: Alberta Government; 2020. https:\/\/open.alberta.ca\/dataset\/568f8505-2304-4ce2-882c-2bbbc314b739\/resource\/94892cea-00e5-4a2b-9633-42163def7ba6\/download\/health-somb-medical-price-list-2020-05.pdf. Accessed 8 Oct 2020."},{"issue":"41","key":"331_CR26","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.21105\/joss.01593","volume":"4","author":"L B\u00f8rty","year":"2019","unstructured":"B\u00f8rty L, Br\u00f8ndum R, B\u00f8gsted M. ccostr: an R package for estimating mean costs with censored data. J Open Source Softw. 2019;4(41):1593.","journal-title":"J Open Source Softw"},{"issue":"3","key":"331_CR27","first-page":"698","volume":"15","author":"S Chen","year":"2015","unstructured":"Chen S, Rolfes J, Zhao H. Estimation of mean health care costs and incremental cost-effectiveness ratios with possibly censored data. Stand Genomic Sci. 2015;15(3):698\u2013711.","journal-title":"Stand Genomic Sci"},{"issue":"5","key":"331_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1038\/s41436-018-0289-9","volume":"21","author":"DA Marshall","year":"2019","unstructured":"Marshall DA, Benchimol EI, MacKenzie A, et al. Direct health-care costs for children diagnosed with genetic diseases are significantly higher than for children with other chronic diseases. Genet Med. 2019;21(5):1049\u201357.","journal-title":"Genet Med"},{"issue":"2","key":"331_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","volume":"3","author":"G Giancane","year":"2016","unstructured":"Giancane G, Consolaro A, Lanni S, Dav\u00ec S, Schiappapietra B, Ravelli A. Juvenile idiopathic arthritis: diagnosis and treatment. Rheumatol Ther. 2016;3(2):187\u2013207.","journal-title":"Rheumatol Ther"},{"issue":"3","key":"331_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2165\/00019053-199915030-00004","volume":"15","author":"C Evans","year":"1999","unstructured":"Evans C, Crawford B. Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Pharmacoeconomics. 1999;15(3):241\u201356.","journal-title":"Pharmacoeconomics"},{"key":"331_CR31","doi-asserted-by":"publisher","first-page":"S632","DOI":"10.1016\/j.jval.2019.09.1207","volume":"22","author":"I van den Berg","year":"2019","unstructured":"van den Berg I, Kip MMA, Marshall DA, et al. Juvenile idiopathic arthritis is associated with considerable financial burden to society: results of a Dutch cost analysis. Value Health. 2019;22:S632.","journal-title":"Value Health"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00331-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T08:16:28Z","timestamp":1629620188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00331-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,18]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["331"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00331-x","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,18]]},"assertion":[{"value":"2 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}